DDX39B is a potent activator of IL7R exon 6 splicing and a repressor of the production of sIL7R (Galarza-Muñoz et al., 2017), which exacerbates the MS-like EAE (Lundström et al., 2013). This evidence concerns the gene DDX39B and myeloid sarcoma.